Skip to main content
. 2018 Jan 6;12(2):196–207. doi: 10.1002/1878-0261.12158

Figure 3.

Figure 3

Comparison of PFS in high‐risk vs. low‐risk patients stratified by IHC signature. (A) Discovery cohort, (B) validation cohort, and (C) the combined cohort of discovery and validation groups.